The resurgence of M&A activities, the profound impact of AI, and the burgeoning advances in RNA technology, CRISPR, bioprinting, tissue engineering, stem cell research, and targeted protein degradation, all represent significant strides in the industry.
As we look toward 2024, the biotech industry’s landscape is undeniably vibrant and brimming with potential. The trends we’ve explored paint a future where innovation is a tangible reality driving the sector forward. The resurgence of M&A activities, the profound impact of AI, and the burgeoning advances in RNA technology, CRISPR, bioprinting, tissue engineering, stem cell research, and targeted protein degradation, all represent significant strides in the industry.